264 related articles for article (PubMed ID: 6813293)
1. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
Flüchter SH; Harzmann R; Erdmann D; Bichler KH
Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
[No Abstract] [Full Text] [Related]
2. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
3. Management of superficial bladder cancer in a community setting.
Haas JA
Urology; 1985 Oct; 26(4 Suppl):51-4. PubMed ID: 3931328
[TBL] [Abstract][Full Text] [Related]
4. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH; Bouffioux C; Sylvester R; de Pauw M
Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
[No Abstract] [Full Text] [Related]
5. [Local mitomycin-C therapy of infiltrating bladder cancer].
Erdmann WD; Harzmann R; Flüchter SH; Bichler KH
Fortschr Med; 1984 Aug; 102(29-30):767-71. PubMed ID: 6437950
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels during intravesical instillation of mitomycin-C.
Kurth KH; de Wall JG; van Oosterom AT; de Jong EA; Tjaden UR
Prog Clin Biol Res; 1985; 185B():81-93. PubMed ID: 3929272
[No Abstract] [Full Text] [Related]
7. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
8. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
Rintala E; Jauhiainen K; Alfthan O
Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
[No Abstract] [Full Text] [Related]
9. [Local chemotherapy of bladder carcinoma with mitomycin (author's transl)].
Flüchter SH; Harzmann R; Hlobil H; Erdmann W; Bichler KH
Urologe A; 1982 Jan; 21(1):24-8. PubMed ID: 6805121
[TBL] [Abstract][Full Text] [Related]
10. Intravesical chemotherapy.
Prout GR
Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
[No Abstract] [Full Text] [Related]
11. [Calcified bladder lesions secondary to the instillation of mitomycin C].
Megias Garrigós J; Pelluch Auladell A; Romero Pérez P; Fernandez García J; Gassó Matoses M; Sánchez Marcos M; Mira Llinarés A
Arch Esp Urol; 1991 Nov; 44(9):1057-60. PubMed ID: 1807206
[TBL] [Abstract][Full Text] [Related]
12. [Effects of mitomycin C perfusion after bladder tumor surgery].
Zhou CL
Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):654-5, 700. PubMed ID: 2517250
[TBL] [Abstract][Full Text] [Related]
13. Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C.
Oosterlinck W
Nat Clin Pract Urol; 2006 Nov; 3(11):582-3. PubMed ID: 17088923
[No Abstract] [Full Text] [Related]
14. [Clinical trials with localized mitomycin instillation therapy for superficial urothelial bladder carcinoma].
Flüchter SH; Bichler KH; Harzmann R; Erdmann D
Onkologie; 1982 Feb; 5(1):42-5. PubMed ID: 6803202
[TBL] [Abstract][Full Text] [Related]
15. [Intravesical chemical prevention of recurrence of superficial urothelial bladder cancer. Progress report of the Urology Clinic of Mainz University 1975-1981].
Jacobi GH; Engelmann U; Frohneberg D; Thüroff JW
Helv Chir Acta; 1982 Aug; 49(3-4):345-8. PubMed ID: 6813292
[No Abstract] [Full Text] [Related]
16. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.
van der Meijden PM; Debruyne FM; Steerenberg PA; de Jong WH; Doesburg W
Prog Clin Biol Res; 1989; 310():285-98. PubMed ID: 2505272
[No Abstract] [Full Text] [Related]
17. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
Zincke H; Benson RC; Hilton JF; Taylor WF
J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
[TBL] [Abstract][Full Text] [Related]
18. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
Giesbers AA; Van Helsdingen PJ; Kramer AE
Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
[TBL] [Abstract][Full Text] [Related]
20. [Effect of etoposide orally administered every other day for the prevention of recurrence of bladder tumor].
Miura K; Yuri Y; Tsukada T
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1375-7. PubMed ID: 2114830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
